Novo Nordisk A/S ADR (NY: NVO )

143.34 +1.56 (+1.10%)
Streaming Delayed Price Updated: 11:20 AM EDT, Jun 12, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
November 12, 2012
Form 6-K
Source: SEC/Edgar
November 12, 2012
Form 6-K
Source: SEC/Edgar
November 12, 2012
Form 6-K
Source: SEC/Edgar
November 12, 2012
Form 6-K
Source: SEC/Edgar
November 12, 2012
Form 6-K
Source: SEC/Edgar
November 08, 2012
Form 6-K
Source: SEC/Edgar
October 30, 2012
Form 6-K
Source: SEC/Edgar
October 29, 2012
Form 6-K
Source: SEC/Edgar
October 25, 2012
Form 6-K
Source: SEC/Edgar
October 22, 2012
Form 6-K
Source: SEC/Edgar
October 21, 2012
Form 6-K
Source: SEC/Edgar
October 01, 2012
Form 6-K
Source: SEC/Edgar
September 30, 2012
Form 6-K
Source: SEC/Edgar
September 30, 2012
Form 6-K
Source: SEC/Edgar
September 27, 2012
Form 6-K
Source: SEC/Edgar
September 25, 2012
Form 6-K
Source: SEC/Edgar
September 03, 2012
Form 6-K
Source: SEC/Edgar
September 03, 2012
Form 6-K
Source: SEC/Edgar
September 03, 2012
Form 6-K
Source: SEC/Edgar
August 20, 2012
Form 6-K
Source: SEC/Edgar
August 12, 2012
Form 6-K
Source: SEC/Edgar
August 08, 2012
Form 6-K
Source: SEC/Edgar
August 06, 2012
Form 11-K
Source: SEC/Edgar
July 31, 2012
Form 11-K
Source: SEC/Edgar
July 31, 2012
Form 6-K
Source: SEC/Edgar
July 30, 2012
Form 6-K
Source: SEC/Edgar
July 17, 2012
Form 6-K
Source: SEC/Edgar
July 08, 2012
Form 6-K
Source: SEC/Edgar
July 01, 2012
Form 6-K
Source: SEC/Edgar
July 01, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.